Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University
Chongqing, China
NCT Number: NCT07548190
This study constitutes a bidirectional cohort investigation. By collating laboratory parameters and clinical data-including plasma and peripheral blood mononuclear cell (PBMC) analyses-from patients with acute-on-chronic liver failure, it aims to provide a reference framework for predicting prognosis and the occurrence of complications.
This study is active but is not currently recruiting participants.
Notify Me18 year–85 year
All sexes
Observational
Chongqing, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
•Clinical diagnosis of Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF)
Exclusion criteria
Time frame: Days 28, 90, 180, and 360
The Second Affiliated Hospital of Chongqing Medical University
Other
Bidirectional Cohort Study on Prognostic Model Construction for Acute-on-Chronic Liver Failure
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05234190
Behavior, Digestive System Diseases
Brussels, Belgium
View Trial DetailsNCT02991105
Cancer, Cardiovascular Diseases
Birmingham, West Midlands, United Kingdom
View Trial DetailsNCT01366144
Adnexal Diseases, Breast Carcinoma
Duarte, California, United States
View Trial DetailsNCT06767553
Biliary Complications, Biliary Stents
Daejeon, South Korea
View Trial Details